Zai Lab (ADR) (ZLAB)
Develops and commercializes therapies through partnerships and internal research.
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≥ 29.44% | 43.10M ADS | |
|---|---|---|---|
| 97 holders · as of Jun 30, 2026 | |||
| Insiders | 1.72% | 2.52M ADS | |
| 14 holders · as of Aug 21, 2026 | |||
| Other | ≤ 68.84% | 100.77M ADS | |
| remainder | |||
146.39M ADS (1 ADS = 10 ordinary shares) as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (146.39M in the company's Sep 22, 2026 report, 112.92M elsewhere); stakes use the report.
Institutional filings for 9688 (768% of the company) are not on file here, so the institutional figure is a floor.
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
97 holders · 43.10M shares · 17 new positions · 46 increased · 28 reduced · 22 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| RTW Investments, LP | 6.57M | 4.49% | 0 | Aug 14, 2026 |
| TCG Crossover Management, LLC | 6.14M | 4.19% | +6.14Mnew | Aug 14, 2026 |
| Ra Capital Management, L.P. | 5.74M | 3.92% | +36.3K | Aug 14, 2026 |
| Adar1 Capital Management, LLC | 3.37M | 2.30% | +1.94M | Aug 14, 2026 |
| FMR LLC | 2.82M | 1.92% | +1.55M | Aug 13, 2026 |
| Goldman Sachs Group Inc | 2.32M | 1.58% | +2.20M | Aug 14, 2026 |
| Woodline Partners LP | 2.21M | 1.51% | +2.21Mnew | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | 1.90M | 1.30% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Ein #incl. Janus Henderson Group plc | 9.20% | 91.59M | Nov 14, 2024 | |
| RTW Investments, LP | 6.30% | 69.59M | 13G | Feb 17, 2026 |
| RA Capital Management, L.P. | 5.20% | 57.44M | 13G | Apr 6, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Yajing Chenofficer: Chief Financial Officer | Sale | 260 | $27.00 | 35,635 |
| Aug 12, 2026 | William Lisdirector | Sale | 8,506 | $25.00 | 41,931 |
| Aug 11, 2026 | Yajing Chenofficer: Chief Financial Officer | Sale | 619 | $25.00 | 35,072 |
| Jul 1, 2026 | Richard Gaynordirector | Purchase | 1,736 | $19.05 | 80,737 |
| Jun 30, 2026 | Ying Dudirector, officer: Chairperson & CEO | Sale | 7,026 | $18.53 | 1,203,784 |
| Jun 26, 2026 | Yajing Chenofficer: Chief Financial Officer | Sale | 2,264 | $17.46 | 35,691 |
| Jun 26, 2026 | Ying Dudirector, officer: Chairperson & CEO | Sale | 24,543 | $17.46 | 1,192,840 |
| Jun 26, 2026 | Frazor Titus III Edmondsonofficer: Chief Legal Officer | Sale | 4,103 | $17.46 | 30,346 |
| Jun 22, 2026 | William Lisdirector | Sale | 7,040 | $18.09 | 50,437 |
| May 18, 2026 | Ying Dudirector, officer: Chairperson & CEO | Sale | 50,000 | $19.00 | 1,122,626 |
House and Senate disclosures
Not reported.